Thermo Fisher Scientific Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Marc N. Casper
- Full Time Employees
- 125,000
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 168 Third Avenue Waltham MA United States 02451
- IPO Date
- Aug 27, 1980
- CIK
- 0000097745
- Website
- corporate.thermofisher.com
- Similar Companies
- Business
- Thermo Fisher Scientific Inc. (NYSE: TMO) provides analytical instruments, equipment, software, services, consumables, and reagents for research, analysis, discovery, and diagnostics worldwide. The company offers products including mass spectrometry systems, chromatography instruments, genetic analysis tools, bioprocessing equipment, clinical diagnostics assays, laboratory automation solutions, and electron microscopy technologies; its key brands encompass Thermo Scientific, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon. Headquartered in Waltham, Massachusetts, Thermo Fisher was originally founded in 1902 through the merger of Fisher Scientific and Thermo Electron in 2006, and operates in over 70 countries serving pharmaceutical, biotechnology, academic, government, and healthcare customers across life sciences, analytical technologies, specialty diagnostics, and laboratory products segments. Recently, the company expanded its capabilities through the acquisition of Olink Holding AB in 2024 to bolster proteomics offerings, launched the new Orbitrap Astral mass spectrometer in late 2024 for high-throughput proteomics, and formed strategic partnerships including a multi-year collaboration with AstraZeneca to advance biomarker discovery; in 2025, Thermo Fisher announced expansions in gene editing technologies and sustainable manufacturing initiatives amid ongoing supply chain optimizations.
Company News
Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings
Diamond Hill Large Cap Fund Q3 2026 Portfolio Update
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
Thermo Fisher Scientific Announces Quarterly Dividend
Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance
Jim Cramer Calls Big Tech ‘Millstones' and Names the ‘New Techs' Taking Over
15,095 Thermo Fisher Scientific Inc. $TMO Shares Sold by Bank Julius Baer & Co. Ltd Zurich
Thermo Fisher Scientific Inc. $TMO Shares Newly Bought by Associated Banc Corp
Thermo Fisher Scientific Inc. $TMO Stock: BOCHK Asset Management Ltd Lowers Position
Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet
Parnassus Value Equity Fund Q3 2026 Portfolio Review
Is TMO Overvalued? DCF Says Worth $352
Baron Health Care Fund Q3 2026 Top Contributors And Detractors
Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More
Thermo Fisher: You Don't Need A Microscope To See The Growth Anymore
Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
Thermo Fisher Stocks Rise 1.0% as Revenue Growth Beats Estimates
Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings
Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript
TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market